Diabetic Neuropathy, Painful Completed Phase 2 Trials for Sofinicline (DB12527)

IndicationStatusPhase
DBCOND0030279 (Diabetic Neuropathy, Painful)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00507936Safety and Efficacy Study in Subjects With Diabetic Neuropathic PainTreatment